Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.47 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | ACACB | O00763 | 1/20 | 0.46 |
| ▸ | CNR2 | P34972 | 1/20 | 0.46 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.46 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.46 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8589119 | 0.85 | L3MBTL1 (0.61) | RAB9AMEN1KMT2AALDH1A1GAA | |
| SCHEMBL2207966 | 0.85 | FFAR1 (0.56) | KMT2AALDH1A1L3MBTL1HTT | |
| SCHEMBL2881396 | 0.85 | ESR1 (0.48) | RAB9AALDH1A1MAPTHTT | |
| SCHEMBL13140497 | 0.85 | ESR1 (0.48) | RAB9AALDH1A1MAPTHTT | |
| SCHEMBL14567176 | 0.85 | ESR1 (0.48) | RAB9AALDH1A1MAPTHTT | |
| SCHEMBL17875268 | 0.85 | ACHE (0.61) | RAB9AMEN1KMT2AALDH1A1GAA | |
| SCHEMBL14349888 | 0.85 | ABCB11 (0.67) | MAPTL3MBTL1LMNA | |
| SCHEMBL15037436 | 0.84 | ALDH1A1 (0.51) | RAB9AMEN1KMT2AALDH1A1GAA | |
| SCHEMBL12430380 | 0.84 | ALOX15 (0.55) | RAB9AMEN1KMT2AALDH1A1GAA | |
| SCHEMBL16509661 | 0.84 | ALOX15 (0.55) | RAB9AMEN1KMT2AALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210040049-A1 | ANTI-HCMV COMPOSITIONS AND METHODS | EVRYS BIO, LLC (US) | 2021-02-11 | — | — | US | disclosed |
| US-10723708-B2 | Anti-HCMV compositions and methods | EVRYS BIO, LLC (US) | 2020-07-28 | — | — | US | disclosed |
| US-20180170884-A1 | ANTI-HCMV COMPOSITIONS AND METHODS | FORGE LIFE SCIENCE, LLC | 2018-06-21 | — | — | US | disclosed |
| CN-107721836-A | One kind synthesis 1,7 2（4 hydroxy phenyls）The method of the ketone of 1,4 diene of heptane 3 | 沈阳药科大学 | 2018-02-23 | — | — | CN | disclosed |
| WO-2016077240-A2 | ANTI-HCMV COMPOSITIONS AND METHODS | FORGE LIFE SCIENCE, LLC (US) | 2016-05-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10723708-B2 | Anti-HCMV compositions and methods | RPL35, RPL7, RPL5 | RAB9A 3682/4885MEN1 3418/4885KMT2A 3889/4885 |
| US-20210040049-A1 | ANTI-HCMV COMPOSITIONS AND METHODS | RPL35, RPL7, RPL5 | RAB9A 3682/4885MEN1 3418/4885KMT2A 3889/4885 |
| US-20180170884-A1 | ANTI-HCMV COMPOSITIONS AND METHODS | RPL35, RPL7, RPL5 | RAB9A 3682/4885MEN1 3418/4885KMT2A 3889/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.